Home›Stock Screener›Remus Pharmaceuticals›Shareholding Pattern

Remus Pharmaceuticals Shareholding Pattern

As of Mar 2026, Remus Pharmaceuticals (REMUS) promoter holding 70.95%, FII 5.28%, DII 0.83%, public 18.50%, total shareholders 2,009. Explore REMUS investment value to estimate fundamental worth using multiple valuation models.

Promoter Holding 70.95%
FII Holding 5.28%
DII Holding 0.83%
Public Holding 18.50%
Total Shareholders 2,009
As of Mar 2026

REMUS Recent Shareholding Changes — Promoter, FII & DII

Remus Pharmaceuticals promoter, FII and DII holding change from Sept 2025 to Mar 2026 — promoter +0.04%, FII +5.28%, DII +0.83%. Browse REMUS annual financials for revenue, profit, balance sheet and cash flow data.

Promoter Holding Change
Sept 2025 to Mar 2026
+0.04%
FII Holding Change
Sept 2025 to Mar 2026
+5.28%
DII Holding Change
Sept 2025 to Mar 2026
+0.83%
Public Holding Change
Sept 2025 to Mar 2026
-0.28%

Remus Pharmaceuticals Quarterly Shareholding Trend — Promoter, FII, DII & Public

REMUS promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see REMUS screener.

Promoter
FII
DII
Public
Government

REMUS Shareholding Pattern Data — Quarterly History

Remus Pharmaceuticals quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 70.95% 5.28% 0.83% 0.00% 18.50% 4.43% 99.99% 2,009
Sept 2025 70.91% 0.00% 0.00% 0.00% 18.78% 10.32% 100.01% 2,032
Jul 2025 70.85% 0.00% 0.00% 0.00% 18.90% 10.25% 100.00% 2,017
Mar 2025 70.85% 0.00% 0.00% 0.00% 19.18% 9.97% 100.00% 398
Sept 2024 70.84% 0.00% 0.00% 0.00% 20.49% 8.67% 100.00% 1,753
Jun 2024 70.66% 0.00% 0.00% 0.00% 20.90% 8.44% 100.00% 1,577
Mar 2024 70.60% 0.00% 0.00% 0.00% 20.54% 8.85% 99.99% 1,124
Sept 2023 69.61% 0.00% 0.00% 0.00% 21.15% 9.24% 100.00% 856
May 2023 68.37% 0.00% 0.92% 0.00% 16.69% 14.02% 100.00% 1,743
Mar 2023 92.82% 0.00% 0.00% 0.00% 6.44% 0.74% 100.00% 30
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 70.95% 5.28% 0.83% 0.00% 18.50% 4.43% 99.99% 2,009
Sept 2025 70.91% 0.00% 0.00% 0.00% 18.78% 10.32% 100.01% 2,032
Jul 2025 70.85% 0.00% 0.00% 0.00% 18.90% 10.25% 100.00% 2,017
Mar 2025 70.85% 0.00% 0.00% 0.00% 19.18% 9.97% 100.00% 398
Sept 2024 70.84% 0.00% 0.00% 0.00% 20.49% 8.67% 100.00% 1,753
Jun 2024 70.66% 0.00% 0.00% 0.00% 20.90% 8.44% 100.00% 1,577
Mar 2024 70.60% 0.00% 0.00% 0.00% 20.54% 8.85% 99.99% 1,124
Sept 2023 69.61% 0.00% 0.00% 0.00% 21.15% 9.24% 100.00% 856
May 2023 68.37% 0.00% 0.92% 0.00% 16.69% 14.02% 100.00% 1,743
Mar 2023 92.82% 0.00% 0.00% 0.00% 6.44% 0.74% 100.00% 30
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 70.95% 5.28% 0.83% 0.00% 18.50% 4.43% 99.99% 2,009
Mar 2025 70.85% 0.00% 0.00% 0.00% 19.18% 9.97% 100.00% 398
Mar 2024 70.60% 0.00% 0.00% 0.00% 20.54% 8.85% 99.99% 1,124
Mar 2023 92.82% 0.00% 0.00% 0.00% 6.44% 0.74% 100.00% 30